-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
2'-Deoxy-2'-fluorouridine
Category | Influenza Virus |
CAS | 784-71-4 |
Description | It is a component incorporated into therapeutic oligonucleotides to combat prostate and breast cancer. |
Product Information
Synonyms | 2'-Fluoro-2'-deoxyuridine; Fioluridine; 1-(2-Deoxy-2-fluoro-β-D-ribofuranosyl)uracil; 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; 2'-Fluoro Uridine; 2'-F-dU; 2'-Fluoro-uridine |
IUPAC Name | 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
Molecular Weight | 246.19 |
Molecular Formula | C9H11FN2O5 |
Canonical SMILES | C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F |
InChI | InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1 |
InChIKey | UIYWFOZZIZEEKJ-XVFCMESISA-N |
Melting Point | 147.0-153.0°C |
Purity | ≥95% |
Density | 1.63±0.1 g/cm3 (Predicted) |
Solubility | Soluble in Methanol |
Appearance | White Crystalline Powder |
Application | Antineoplastic Agents |
Storage | Store at 2-8°C |
Exact Mass | 692.16800 |
PSA | 189.62000 |
Target | Influenza Virus |